Baker Hughes Co (BKR) is slightly overvalued and NOV Inc (NOV) is overvalued.
Both trade above our estimate of their intrinsic value. BKR is the closer of the two: -19%, against -83% for NOV.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 9.8% (average of 3 methods) values the shares at $48.25; the price of $57.26 is 19% above that value, and 73% of that value comes from beyond year five.
Leak Score 51/100 on 9 of 12 signals
Discounting its cash flows at 8.8% (average of 3 methods) values the shares at $11.05; the price of $20.18 is 83% above that value, and 77% of that value comes from beyond year five.
Leak Score 0/100 on 3 of 12 signals
| Metric | BKR | NOV |
|---|---|---|
| Verdict | Slightly overvalued | Overvalued |
| Price | $57.26 | $20.18 |
| Intrinsic value | $48.25 | $11.05 |
| Margin of safety | -19% | -83% |
| Leak Score | 51/100 (9/12) | 0/100 (3/12) |
| Market cap | $56.8B | $7.2B |
| Revenue growth, 5 years | 6.0% | 7.6% |
| Operating margin | 13.0% | 6.9% |
| Net margin | 11.2% | 1.1% |
| Return on equity | 16.5% | 1.5% |
| Debt to equity | 0.82 | 0.37 |
| P/E | 18.4x | 77.5x |
| Forward P/E | 18.9x | 15.9x |
| P/B | 2.9x | 1.2x |
| Dividend yield | 1.6% | 2.2% |